Overview
Patrizia Ianes practices practicing medicine in Pergine Valsugana, Italy.
Her clinical expertise encompasses Dravet Syndrome, Myoclonic Epilepsy, Epilepsy with Myoclonic-Atonic Seizures, and Epilepsy.
She is actively involved in clinical research, co-authoring 8 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Patrizia G. Ianes
Is Patrizia G. Ianes a top-rated expert for Dravet Syndrome?
MediFind is an objective health platform that identifies experts based on real-world data. Patrizia G. Ianes is classified as an Experienced expert for Dravet Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Patrizia G. Ianes participate in research or clinical trials?
Yes. Patrizia G. Ianes has published 8 articles and abstracts on conditions like Dravet Syndrome. You can view a list of Patrizia G. Ianes's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Dravet SyndromeMs. Ianes isExperienced. Learn about Dravet Syndrome.
- EpilepsyMs. Ianes isExperienced. Learn about Epilepsy.
- Epilepsy with Myoclonic-Atonic Seizures
- Myoclonic EpilepsyMs. Ianes isExperienced. Learn about Myoclonic Epilepsy.